APA (7th ed.) Citation

File, T. M., Goldberg, L., Das, A., Sweeney, C., Saviski, J., Gelone, S. P., . . . Gasink, L. B. (2020). Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial. Clinical Infectious Diseases, 70(11), 2459. https://doi.org/10.1093/cid/ciz710

Chicago Style (17th ed.) Citation

File, Thomas M., et al. "Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial." Clinical Infectious Diseases 70, no. 11 (2020): 2459. https://doi.org/10.1093/cid/ciz710.

MLA (9th ed.) Citation

File, Thomas M., et al. "Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial." Clinical Infectious Diseases, vol. 70, no. 11, 2020, p. 2459, https://doi.org/10.1093/cid/ciz710.